WuXi Biologics (Cayman) Inc
HKEX:2269

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
HKEX:2269
Watchlist
Price: 39.78 HKD -0.6% Market Closed
Market Cap: 164.2B HKD

Wall Street
Price Targets

Price Targets Summary
WuXi Biologics (Cayman) Inc

Wall Street analysts forecast WuXi Biologics (Cayman) Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 40.89 HKD with a low forecast of 30.3 HKD and a high forecast of 54.6 HKD.

Lowest
Price Target
30.3 HKD
24% Downside
Average
Price Target
40.89 HKD
3% Upside
Highest
Price Target
54.6 HKD
37% Upside
WuXi Biologics (Cayman) Inc Competitors:
Price Targets
TES
Tesmec SpA
12% Upside
SCM
Solutions Capital Management SIM SpA
42% Upside
GLSI
Greenwich Lifesciences Inc
95% Upside

Revenue
Forecast

Revenue Estimate
WuXi Biologics (Cayman) Inc

For the last 9 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's revenue is 48%. The projected CAGR for the next 4 years is 17%.

48% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
WuXi Biologics (Cayman) Inc

For the last 9 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's operating income is 62%. The projected CAGR for the next 4 years is 22%.

62% / Year
Past Growth
22% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
WuXi Biologics (Cayman) Inc

For the last 9 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's net income is 62%. The projected CAGR for the next 4 years is 24%.

62% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WuXi Biologics (Cayman) Inc's stock price target?
Price Target
40.89 HKD

According to Wall Street analysts, the average 1-year price target for WuXi Biologics (Cayman) Inc is 40.89 HKD with a low forecast of 30.3 HKD and a high forecast of 54.6 HKD.

What is WuXi Biologics (Cayman) Inc's Revenue forecast?
Projected CAGR
17%

For the last 9 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's revenue is 48%. The projected CAGR for the next 4 years is 17%.

What is WuXi Biologics (Cayman) Inc's Operating Income forecast?
Projected CAGR
22%

For the last 9 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's operating income is 62%. The projected CAGR for the next 4 years is 22%.

What is WuXi Biologics (Cayman) Inc's Net Income forecast?
Projected CAGR
24%

For the last 9 years the compound annual growth rate for WuXi Biologics (Cayman) Inc's net income is 62%. The projected CAGR for the next 4 years is 24%.

Back to Top